By Anthony O. Goriainoff Syncona said portfolio company Anaveon will present updated clinical data from the continuing phase I dose escalation study of the…
Markets – MarketWatch
Syncona Portfolio Company to Present Updated Data on Cancer Study Markets – MarketWatch
